Status:
COMPLETED
Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)
Lead Sponsor:
AstraZeneca
Conditions:
Hypertension
Left Ventricular Hypertrophy
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate effect of candesartan based therapy on percent change of B type natriuretic peptides(BNP) level in the subjects with hypertension and left ventricular hyper...
Eligibility Criteria
Inclusion
- Hypertension with diastolic blood pressure within 95-115 mm/Hg or/and systolic blood pressure within 160-200 mm/Hg
- Patients diagnosed as left ventricular hypertrophy by electrocardiogram
Exclusion
- Secondary hypertension
- History of myocardial infarction
- Stroke within the previous 6 months
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
315 Patients enrolled
Trial Details
Trial ID
NCT00348686
Start Date
June 1 2006
End Date
June 1 2008
Last Update
April 2 2012
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Busan, South Korea
2
Research Site
Cheonan, South Korea
3
Research Site
Cheongju-si, South Korea
4
Research Site
Chunbuk, South Korea